The Netherlands adds AI, biotech, nanotechnology, and three other sectors to its investment screening regime from January 2027, affecting hundreds of companies after the Nexperia debacle.

The Netherlands expands its Vifo Act investment screening regime to cover AI, biotech, and four other sensitive technologies, tightening foreign acquisition

The Netherlands adds AI, biotech, nanotechnology, and three other sectors to its investment screening regime from January 2027, affecting hundreds of companies after the Nexperia…